Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A. M. Carella, MD, G. Beltrami, MD, G. Pica, MD, C. Ghiggi, MD, D. Lovera, MD, G. Cirmena, A. Garuti

Blood (2012) 120 (21): 3777.

https://doi.org/10.1182/blood.V120.21.3777.3777

Published: 2012

Journal Articles

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

G. Pica, S. Vagge, G. Beltrami, S. Nati, G. Catania, R. Corvò, A. M. Carella, MD

Blood (2011) 118 (21): 4523.

https://doi.org/10.1182/blood.V118.21.4523.4523

Published: 2011

Journal Articles

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

A. M. Carella, MD, Gioacchino Catania, MD, G. Beltrami, G. Pica

Blood (2011) 118 (21): 4450.

https://doi.org/10.1182/blood.V118.21.4450.4450

Published: 2011

Journal Articles

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

A. M. Carella, G. Catania, G. Pica and G. Beltrami

Blood (2010) 116 (21): 4486.

https://doi.org/10.1182/blood.V116.21.4486.4486

Published: 2010

Journal Articles

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

A. M. Carella, A. Garuti, G. Cirmena, G. Catania, G. Pica, G. Beltrami, F. Patrone

Blood (2010) 116 (21): 4458.

https://doi.org/10.1182/blood.V116.21.4458.4458

Published: 2010

Journal Articles

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

A. M. Carella, G. Catania, G. Pica, G. Beltrami, S. Nati, R. Vimercati, A. Congiu, E. Rossi, M. Spriano

Blood (2009) 114 (22): 4109.

https://doi.org/10.1182/blood.V114.22.4109.4109

Published: 2009

Journal Articles

Autografting Followed Closely by Nonmyeloablative Allografting as Consolidation Immunotherapy Reduces Disease Progression Compared to Tandem Autografting in Multiple Myeloma.

A.M. Carella, MD, M. Spriano, MD, M. T. Corsetti, MD, P. Scalzulli, MD, G. Beltrami, MD, E. Lerma, MD, PhD, N. Cascavilla, MD, M. Carella, MD, S. Nati, MD, A. Congiu, MD, P. Musto, MD

Blood (2005) 106 (11): 1126.

https://doi.org/10.1182/blood.V106.11.1126.1126

Published: 2005

NARROW

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

Autografting Followed Closely by Nonmyeloablative Allografting as Consolidation Immunotherapy Reduces Disease Progression Compared to Tandem Autografting in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

Autografting Followed Closely by Nonmyeloablative Allografting as Consolidation Immunotherapy Reduces Disease Progression Compared to Tandem Autografting in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only